The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Paediatric Vaccine Market Research Report 2024
Synopsis
The global Paediatric Vaccine market was valued at US$ 21400 million in 2023 and is anticipated to reach US$ 31130 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Paediatric Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paediatric Vaccine.
Report Scope
The Paediatric Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paediatric Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paediatric Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Segment by Type
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines
Segment by Application
Age (0-3)
Age (3-12)
Age Above 12
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Paediatric Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Paediatric Vaccine market was valued at US$ 21400 million in 2023 and is anticipated to reach US$ 31130 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Paediatric Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paediatric Vaccine.
Report Scope
The Paediatric Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paediatric Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paediatric Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Segment by Type
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines
Segment by Application
Age (0-3)
Age (3-12)
Age Above 12
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Paediatric Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paediatric Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pneumococcal
1.2.3 Varicella
1.2.4 Combinations
1.2.5 Poliovirus
1.2.6 Hepatitis
1.2.7 MMR
1.2.8 Pediatric Hormones
1.2.9 HIB
1.2.10 Allergy and Respiratory vaccines
1.2.11 Other Pediatric vaccines
1.3 Market by Application
1.3.1 Global Paediatric Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Age (0-3)
1.3.3 Age (3-12)
1.3.4 Age Above 12
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Paediatric Vaccine Market Perspective (2019-2030)
2.2 Paediatric Vaccine Growth Trends by Region
2.2.1 Global Paediatric Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Paediatric Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Paediatric Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Paediatric Vaccine Market Dynamics
2.3.1 Paediatric Vaccine Industry Trends
2.3.2 Paediatric Vaccine Market Drivers
2.3.3 Paediatric Vaccine Market Challenges
2.3.4 Paediatric Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paediatric Vaccine Players by Revenue
3.1.1 Global Top Paediatric Vaccine Players by Revenue (2019-2024)
3.1.2 Global Paediatric Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Paediatric Vaccine Revenue
3.4 Global Paediatric Vaccine Market Concentration Ratio
3.4.1 Global Paediatric Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paediatric Vaccine Revenue in 2023
3.5 Paediatric Vaccine Key Players Head office and Area Served
3.6 Key Players Paediatric Vaccine Product Solution and Service
3.7 Date of Enter into Paediatric Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paediatric Vaccine Breakdown Data by Type
4.1 Global Paediatric Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Paediatric Vaccine Forecasted Market Size by Type (2025-2030)
5 Paediatric Vaccine Breakdown Data by Application
5.1 Global Paediatric Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Paediatric Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Paediatric Vaccine Market Size (2019-2030)
6.2 North America Paediatric Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Paediatric Vaccine Market Size by Country (2019-2024)
6.4 North America Paediatric Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Paediatric Vaccine Market Size (2019-2030)
7.2 Europe Paediatric Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Paediatric Vaccine Market Size by Country (2019-2024)
7.4 Europe Paediatric Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Paediatric Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Paediatric Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Paediatric Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Paediatric Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Paediatric Vaccine Market Size (2019-2030)
9.2 Latin America Paediatric Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Paediatric Vaccine Market Size by Country (2019-2024)
9.4 Latin America Paediatric Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paediatric Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Paediatric Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Paediatric Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Paediatric Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithCline
11.1.1 GlaxoSmithCline Company Detail
11.1.2 GlaxoSmithCline Business Overview
11.1.3 GlaxoSmithCline Paediatric Vaccine Introduction
11.1.4 GlaxoSmithCline Revenue in Paediatric Vaccine Business (2019-2024)
11.1.5 GlaxoSmithCline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Paediatric Vaccine Introduction
11.2.4 Merck Revenue in Paediatric Vaccine Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Paediatric Vaccine Introduction
11.3.4 Sanofi Revenue in Paediatric Vaccine Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Paediatric Vaccine Introduction
11.4.4 Bristol-Myers Squibb Revenue in Paediatric Vaccine Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Paediatric Vaccine Introduction
11.5.4 Abbott Laboratories Revenue in Paediatric Vaccine Business (2019-2024)
11.5.5 Abbott Laboratories Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Paediatric Vaccine Introduction
11.6.4 Eli Lilly Revenue in Paediatric Vaccine Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Paediatric Vaccine Introduction
11.7.4 Pfizer Revenue in Paediatric Vaccine Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Detail
11.8.2 F. Hoffmann-La Roche Business Overview
11.8.3 F. Hoffmann-La Roche Paediatric Vaccine Introduction
11.8.4 F. Hoffmann-La Roche Revenue in Paediatric Vaccine Business (2019-2024)
11.8.5 F. Hoffmann-La Roche Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Detail
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Paediatric Vaccine Introduction
11.9.4 Novo Nordisk Revenue in Paediatric Vaccine Business (2019-2024)
11.9.5 Novo Nordisk Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
